Daniel W. Muehl

2018 - Clovis Oncology

In 2018, Daniel W. Muehl earned a total compensation of $1.5M as Senior VP of Finance, Principal Accounting Officer, and Principal Financial Officer at Clovis Oncology, a 20% decrease compared to previous year.

Compensation breakdown

Bonus$156,169
Option Awards$388,014
Salary$424,000
Stock Awards$525,870
Other$15,530
Total$1,509,583

Muehl received $525.9K in stock awards, accounting for 35% of the total pay in 2018.

Muehl also received $156.2K in bonus, $388K in option awards, $424K in salary and $15.5K in other compensation.

Rankings

In 2018, Daniel W. Muehl's compensation ranked 7,127th out of 14,244 executives tracked by ExecPay. In other words, Muehl earned more than 50.0% of executives.

ClassificationRankingPercentile
All
7,127
out of 14,244
50th
Division
Manufacturing
2,744
out of 5,758
52nd
Major group
Chemicals And Allied Products
1,032
out of 2,119
51st
Industry group
Drugs
871
out of 1,808
52nd
Industry
Pharmaceutical Preparations
680
out of 1,382
51st

Pay ratio

Daniel W. Muehl's Pay$1,509,583
Median Employee's Pay$349,809
Pay Ratio

4

to 1

In 2018, the annual total compensation of Daniel W. Muehl was $1,509,583.

The annual total compensation of the median employee at Clovis Oncology was $349,809.

The ratio of Daniel W. Muehl's pay to the pay of median employee was therefore 4 to one.

Source: SEC filing on April 26, 2019.

Muehl's colleagues

We found four more compensation records of executives who worked with Daniel W. Muehl at Clovis Oncology in 2018.

2018

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

2018

Lindsey Rolfe

Clovis Oncology

Chief Medical Officer

2018

Gillian Ivers-Read

Clovis Oncology

EVP and Chief Regulatory Officer

2018

C Hooks

Clovis Oncology

Former Senior VP and Chief Commercial Officer

News

You may also like